Search Results - "Pohlmann PR"

Tumor size as a surrogate end point for the detection of early breast cancer: a 30-year (1972-2002), single-center experience in southern Brazil.

Authors: Menke CH Pohlmann PR Backes A et al.

Source: Breast Journal. Sep/Oct2007, Vol. 13 Issue 5, p448-456. 9p.

URL: 26334487

Chemotherapy and immunotherapy in metastatic colorectal cancer.

Authors: Pohlmann PR Mernaugh RL Goff LW et al.

Source: New England Journal of Medicine. 5/14/2009, Vol. 360 Issue 20, p2134-2136. 3p.

Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity.

Authors: Torrado C Andersen CR Kang L et al.

Source: The oncologist [Oncologist] 2026 Mar 09; Vol. 31 (4).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event Reporting.

Authors: Pasricha ND Kim SK Farooq AV et al.

Source: JAMA ophthalmology [JAMA Ophthalmol] 2026 Jan 01; Vol. 144 (1), pp. 62-68.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE

Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.

Authors: Magbanua MJM Manon NA Wolf DM et al.

Source: Nature communications [Nat Commun] 2025 Dec 09; Vol. 16 (1), pp. 9945. Date of Electronic Publication: 2025 Dec 09.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach.

Authors: Adesoye T Dumbrava EE Raghav KPS et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jan 16; Vol. 32 (2), pp. 260-290.

Publication Type: Journal Article; Review

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial.

Authors: Chen WY Ballman KV Partridge AH et al.

Source: JAMA [JAMA] 2024 May 28; Vol. 331 (20), pp. 1714-1721.

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit.

Authors: Braganca Xavier C Andersen CR Lim J et al.

Source: Cancer research communications [Cancer Res Commun] 2025 Sep 01; Vol. 5 (9), pp. 1631-1641.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.

Authors: Reiss KA Angelos MG Dees EC et al.

Source: Nature medicine [Nat Med] 2025 Apr; Vol. 31 (4), pp. 1171-1182. Date of Electronic Publication: 2025 Feb 07.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer.

Authors: Gouda MA Gonugunta A Dumbrava EE et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Apr 01; Vol. 31 (7), pp. 1268-1274.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial.

Authors: Okines AFC Curigliano G Mizuno N et al.

Source: Nature medicine [Nat Med] 2025 Mar; Vol. 31 (3), pp. 909-916. Date of Electronic Publication: 2025 Jan 17.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial.

Authors: Huppert LA Wolf D Yau C et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2025 Feb; Vol. 36 (2), pp. 172-184. Date of Electronic Publication: 2024 Oct 28.

Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers.

Authors: Heeke AL Elliott A O'Keefe K et al.

Source: JCO precision oncology [JCO Precis Oncol] 2025 Jan; Vol. 9, pp. e2300719. Date of Electronic Publication: 2025 Jan 31.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane.

Authors: Pohlmann PR Graham D Wu T et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Dec; Vol. 196 (3), pp. 571-581. Date of Electronic Publication: 2022 Oct 25.

Publication Type: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Molecular characterization of ESR1 variants in breast cancer.

Authors: Heeke AL Elliott A Feldman R et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Nov; Vol. 196 (2), pp. 279-289. Date of Electronic Publication: 2022 Sep 20.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.

Authors: Tarantino P Tayob N Villacampa G et al.

Corporate Authors: Tarantino P Tayob N Villacampa G et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Nov; Vol. 42 (31), pp. 3652-3665. Date of Electronic Publication: 2024 Jun 27.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study; Comparative Study

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions.

Authors: Onzi GR D'Agustini N Garcia SC et al.

Source: Drug safety [Drug Saf] 2022 Jun; Vol. 45 (6), pp. 601-621. Date of Electronic Publication: 2022 May 23.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE

Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.

Authors: Jones BC Pohlmann PR Clarke R et al.

Source: Cancer metastasis reviews [Cancer Metastasis Rev] 2022 Jun; Vol. 41 (2), pp. 447-458. Date of Electronic Publication: 2022 Apr 14.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8605731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7233 (Electronic) Linking ISSN: 01677659 NLM ISO Abbreviation: Cancer Metastasis Rev Subsets: MEDLINE

Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial.

Authors: Barroso-Sousa R Tarantino P Tayob N et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2022 Feb 16; Vol. 8 (1), pp. 18. Date of Electronic Publication: 2022 Feb 16.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.

Authors: Yee D Isaacs C Wolf DM et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2021 Oct 05; Vol. 7 (1), pp. 131. Date of Electronic Publication: 2021 Oct 05.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE